NCT05689853 2026-03-18
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
Akeso
Phase 1/2 Recruiting
Akeso
BioInvent International AB
Corbus Pharmaceuticals Inc.
DualityBio Inc.
Accession Therapeutics Limited
Suzhou Abogen Biosciences Co., Ltd.
Tianjin Medical University Second Hospital
Effector Therapeutics
Grit Biotechnology
Shanghai Huaota Biopharmaceutical Co., Ltd.